-
Sector Analysis
Graft Versus Host Disease (GvHD) - Forecast in Asia-Pacific Markets to 2028
Graft versus host disease (GvHD) is a morbid disease and accounts for the highest cause of non-relapse mortality following allogeneic hematopoietic stem cell transplant (HSCT). Mortality is caused by either extensive tissue damage or uncontrolled opportunistic infection due to the immunosuppressive properties of the current GvHD treatment. Drug-related toxicity issues also contribute significantly to morbidity and mortality in GvHD. The GvHD market is expected to undergo significant change and growth over the next 10 years across the five growth pharmaceutical...
-
Sector Analysis
Axial Spondyloarthritis - Forecast in Asia-Pacific Markets to 2028
Axial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). These conditions are chronic, autoinflammatory disorders of the sacroiliac joints and spine, an area also known as the axial skeleton. The disease is typically diagnosed in young adulthood to middle age (16–45 years) and has a seven- to nine-year delay of diagnosis. The axSpA market has historically been reliant on anti-tumor necrosis factor (TNF) therapies that have been available for over a decade,...
-
Product Insights
Hematopoietic Stem Cell Transplantation Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H1, 2020" provides an overview of Hematopoietic Stem Cell Transplantation Clinical trials scenario. This report provides top line data relating to the clinical trials on Hematopoietic Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
Rheumatoid Arthritis - Epidemiology Forecast to 2029
Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. The condition manifests itself in multiple joints in the body. RA is the result of an immune response in which the body’s immune system attacks its own healthy cells, especially the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response. GlobalData epidemiologists utilized county-specific studies published in peer-reviewed journals to build the forecast....
-
Sector Analysis
Digital Landscape: Rheumatoid Arthritis
The Digital Landscape Rheumatoid Arthritis report analyzes digital activities undertaken by pharma in support of therapies for moderate-to-severe rheumatoid arthritis (RA).
-
Product Insights
Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Global Clinical Trials Review, H2, 2018" provides an overview of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener's Granulomatosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
Digital Landscape: Ankylosing Spondylitis
The Digital Landscape Ankylosing Spondylitis report analyzes digital activities undertaken by pharma in support of therapies for active Ankylosing Spondylitis (AS)
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Angioedema Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Angioedema Global Clinical Trials Review, H2, 2018" provides an overview of Angioedema clinical trials scenario. This report provides top line data relating to the clinical trials on Angioedema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Consumer Insights
KOL Perspectives: Perceptions of Lupus Pipeline Therapy Data Presented at EULAR 2018
This KOL Insight briefing focuses on KOLs views of Pipeline Therapy Data Presented at EULAR 2018
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.